---
id: 87.CI167
birth: -2m
patient:
  fhir:
    gender: female
observation:
  anaphylactic:
    code:
      code: DE161
      system: "http://smart.who.int/immunizations/CodeSystem/IMMZ.D"
      display: "Potential contraindications"
    fhir:
      effectiveDateTime: -5m
      valueCodeableConcept:
        coding:
          code: DE167
          system: "http://smart.who.int/immunizations/CodeSystem/IMMZ.D"
          display: "Severe allergic reactions"
medicationrequest:
  measles:
    medication:
      code: XM5V19
      system: "http://id.who.int/icd/release/11/mms"
      display: "Poliomyelitis, trivalent, inactivated, whole virus"
    fhir:
      authoredOn: 0d
      status: draft
      intent: proposal
---
id: 88.CI200
birth: -2m
patient:
  fhir:
    gender: female
observation:
  anaphylactic:
    code:
      code: DE161
      system: "http://smart.who.int/immunizations/CodeSystem/IMMZ.D"
      display: "Potential contraindications"
    fhir:
      effectiveDateTime: -5m
      valueCodeableConcept:
        coding:
          code: DE200
          system: "http://smart.who.int/immunizations/CodeSystem/IMMZ.D"
          display: "Severely immunocompromised"
medicationrequest:
  measles:
    medication:
      code: XM79H3
      system: "http://id.who.int/icd/release/11/mms"
      display: "Poliomyelitis oral, bivalent, live attenuated"
    fhir:
      authoredOn: 0d
      status: draft
      intent: proposal
---
id: 89.CI187
birth: -25y
patient:
  fhir:
    gender: female
observation:
  anaphylactic:
    code:
      code: DE161
      system: "http://smart.who.int/immunizations/CodeSystem/IMMZ.D"
      display: "Potential contraindications"
    fhir:
      effectiveDateTime: -5m
      valueCodeableConcept:
        coding:
          code: DE187
          system: "http://smart.who.int/immunizations/CodeSystem/IMMZ.D"
          display: "Immunodeficiency syndromes"
medicationrequest:
  measles:
    medication:
      code: XM79H3
      system: "http://id.who.int/icd/release/11/mms"
      display: "Poliomyelitis oral, bivalent, live attenuated"
    fhir:
      authoredOn: 0d
      status: draft
      intent: proposal
